Status:
COMPLETED
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Vaccines, Pneumococcal Conjugate Vaccine
Eligibility:
All Genders
Brief Summary
To collect post-marketing information on the safety of Prevenar in Filipino patients
Eligibility Criteria
Inclusion
- All patients from the study center who received or will receive at least one dose of Prevenar according to the approved product indication.
Exclusion
- Previously discontinued Prevenar therapy due to safety concerns.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
3366 Patients enrolled
Trial Details
Trial ID
NCT00683410
Start Date
April 1 2007
End Date
October 1 2009
Last Update
November 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Muntinlupa, Philippines